海翔药业出资1亿设立合伙企业投资复宏汉霖 因其私有化方案未通过而未达成生效条件

财中社
23 Jan

财中社1月23日电海翔药业(002099)发布公告,关于参投合伙企业投资复宏汉霖的进展情况。公司决定出资1亿,参与设立合伙企业,该合伙企业专门投资于复宏汉霖的非上市股份。近期,复宏汉霖的私有化方案在临时股东大会上获得三分之二以上有表决权股东的批准,但在H股类别股东大会上未获通过,导致本次交易协议的生效条件未达成,私有化方案将不予实施,复宏汉霖将继续保留其H股上市地位。此次投资的核心事件是复宏汉霖...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10